Survival in patients with recurrent squa
β
Mario Airoldi; Antonella De Stefani; Sara Marchionatti; Fulvia Pedani; Pietro Ga
π
Article
π
2001
π
John Wiley and Sons
π
English
β 94 KB
π 2 views
## Abstract ## Background We have shown that rILβ2 administration in recurrent head and neck cancers induces a tumorβspecific Tβlymphocyte reactivity and tumor regression; in a pilot study we have shown a safe and effective administration of rIL2 after cisplatin + 5βfluorouracil. Longβterm results